Please login to the form below

Aspen

This page shows the latest Aspen news and features for those working in and with pharma, biotech and healthcare.

Grünenthal buys Zomig rights as AZ slimming drive continues

This work has seen it agree deals with TerSera Therapeutics ($320m for Zoladex), ProStakan ($70m for Moventig), Aspen ($770m for seven anaesthetics drugs) and, most recently, Recordati ($300m for two blood

Latest news

EU starts investigation of Aspen's cancer drug pricing

EU starts investigation of Aspen's cancer drug pricing. Amid reports of price increases of several hundred per cent. ... Aspen Pharmacare is under investigation by the EU's competition authorities over its pricing of five cancer medicines, amid
Italian pharma scandals prompts call for EU-wide pricing probe

Italian pharma scandals prompts call for EU-wide pricing probe. Aspen fined 5.2m for threat to halt supply of cancer drugs if price hikes not accepted. ... The negotiation strategy adopted by Aspen was so aggressive as to reach the credible threat of
AstraZeneca sells rights to seven anaesthetics in $770m deal

AstraZeneca sells rights to seven anaesthetics in $770m deal. Ten-year agreement with Aspen continues the streamlining of its operations. ... AstraZeneca has divested seven drugs from its anaesthetics portfolio through a $770m deal with Aspen Global
Endo buys Par for $8bn as M&A mania marches on

All told Endo has already spent around $10bn on M&A in recent months, closing a generics deal with South Africa's Aspen Holdings earlier this month.
GSK sells another chunk of South Africa's Aspen

GSK sells another chunk of South Africa's Aspen. Paid $418m for an 18% share in Aspen in 2009. ... We continue to believe in the strategy of Aspen and we remain committed to working together in the future," said Dingemans.

More from news
Approximately 7 fully matching, plus 22 partially matching documents found.

Latest Intelligence

Deal Watch October 2016

$330m. Neurology 2016. Aspen. 5 anesthetics. $770m royalties. $592m. 1.3. Neurology 2014.
Deal Watch September 2016

Reflecting a long standing business relationship, Aspen paid GSK £180m to acquire Ultiva, Nimbex, Tracrium, Mivacron and Anectinein, plus up to £100m in milestone payments. ... 500. GSK / Aspen. Asset acquisition. Sale of anaesthetic drugs [Ultiva,
Deal Watch June 2016

Meanwhile AstraZeneca has out-licensed ex-US rights to a portfolio of seven anaesthetics to Aspen. ... Paying $520m upfront Aspen gains access to a series of local anaesthetics including Marcaine (bupivacaine) and Xylocaine (lidocaine/ lignocaine), and
Pharma deals in May 2015

360. Aspen/ Strides Arcolab. Divestment. Range of branded and generic drugs.
Deal Watch table for January 2015

Licence, option and collaboration. 164. Novartis/Aspen. Purchase of the heparin based anticoagulant Mono-Embolex, with sales of 68m in 2013.

More from intelligence
Approximately 0 fully matching, plus 12 partially matching documents found.

Latest from PMHub

Competition from within

Teva (Israel), CSL (Australia) and Aspen (South Africa) are notable exceptions, with the Indian generic giants Sun and Ranbaxy - which have since merged - the only representation from the ‘ BRIC’ markets (Brazil,
Compliance Hub Ltd

Address:. Aspen Farm. Sheep Lane Woburn. Bedfordshire. MK17 9HD. UK.

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Senior Medical Writer: Salary is DOE

Account Manager: Negotiable

Leadership opportunity, Pricing & Market Access, UK, Substan...: Substantial six figure package

Account Director, Healthcare Communications Agency: £54, 000- £60, 000

Head of Market Access - International - Based Cambridge: Excellent Basic, Bonus and Flex Benefits

Healthcare PR Director: £100, 000 – £120, 000 benefits

Account Manager- 4 days per week or full-time: Salary TBC

Sudler London - Account Director: Competitive

Senior Medical Writer, MedComms Agency: £40 - 55, 000 according to skills and experience benefits

Integrated Brand/ Digital Senior Account Director, London: Excellent package

Senior Writer, Healthcare Advertising, London: Excellent package

Senior Account Manager / Account Director - Medical Education – ...: Salary TBC

Scientific Director – Medical Communications - New York or Remot...: $100000 - $150000

Principal Medical Writer / Editorial Director – Medical Communic...: £60, 000 - £80, 000

Associate Scientific Director: Salary TBC

Account Manager, MedicalCommunications/ Healthcare PR: benefits

Senior Account Manager – Healthcare Advertising: Salary TBC

Market Access Consultant - Greater Manchester: Negotiable

Graduate Scientific Editor: DOE

Senior Strategist/ Planner, Healthcare Marketing, London: Excellent package

Account Director, Healthcare Advertising Agency: Salary TBC

Senior Training Manager - Surrey: Competitive Salary &Bonus

Healthcare PR Senior Account Manager: Salary TBC

Deputy Managing Director – Healthcare PR – Global Agency: Negotiable

Medical Writer - Creative and Scientific Projects: DOE

Subscribe to our email news alerts

PMHub

Add my company

Four Health

Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...

Latest intelligence

PM Society Digital Awards – the power of together: Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduce anyone in four simple steps: You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government: GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....